AURKB and non-small cell lung carcinoma: Further, Aurora-B is a therapeutic target in non-small cell lung cancer refractory to anti-EGFR therapy [18].Our previous study indicated that the expression of Aurora-B is elevated in OS tissues and cell lines, and that silencing of Aurora-B inhibited the malignant phenotype of OS cells in vitro [19].